The ability to correct disease-causing genetic mistakes using genome editors holds great promise in medicine, but it is not ...

On Thursday, the U.S. Food and Drug Administration (FDA) approved Ionis Pharmaceuticals, Inc.’s (NASDAQ:IONS) Dawnzera ...

The approval makes donidalorsen the only treatment in the US for hereditary angioedema that is an RNA-targeted prophylactic.

The ability to correct disease-causing genetic mistakes using genome editors holds great promise in medicine, but it is not without risk. When this type of "genetic surgery" is performed on DNA, for ...

In the past decade there has been significant interest in studying the expression of our genetic code down to the level of ...

In 1957, just four years after Francis Crick and other scientists solved the riddle of DNA’s structure—the now famous double ...

As aging progresses, the quality of DNA and proteins inside cells declines, which is known to be the cause of various ...

Using artificial intelligence, MIT researchers have come up with a new way to design nanoparticles that can more efficiently ...

The collaboration will explore RNA-based small molecule drug candidates aimed at neurological conditions where existing ...

The quest for a vaccine against HIV has been going on for about 40 years — almost as long as the virus that causes AIDS has ...

A previously unknown virus in farmed Pacific oysters may hold the key to mass die-offs in the multimillion-dollar industry, according to research from the University of British Columbia (UBC) in ...